Nabriva Therapeutics plc

DB:NTY Rapporto sulle azioni

Cap. di mercato: €1.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Nabriva Therapeutics Gestione

Gestione criteri di controllo 1/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

H. Hogan

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del management1.3yrs
Durata media del Consiglio di amministrazione6.4yrs

Aggiornamenti recenti sulla gestione

Recent updates


AMMINISTRATORE DELEGATO

H. Hogan (60 yo)

less than a year

Mandato

Mr. H. Michael Hogan III is Chief Executive Officer of Nabriva Therapeutics plc from July 6, 2023. He serves as Director of Metacrine, Inc. since March 23, 2023. He is Director of Otonomy, Inc. from Februa...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Colin Broom
Director6.2yrsUS$40.00k0.042%
$ 663.6
H. Hogan
Chief Executive Officerless than a yearNessun datoNessun dato
David Maggio
Chief Financial Officerless than a yearNessun datoNessun dato
J. Naftzger
General Counsel & Secretary2.2yrsNessun datoNessun dato

1.3yrs

Durata media

62yo

Età media

Gestione esperta: NTY's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Colin Broom
Director6.4yrsUS$40.00k0.042%
$ 663.6
Daniel Burgess
Independent Chairman of the Board6.4yrsUS$90.00k0.013%
$ 201.1
Mark H. Corrigan
Independent Director2.4yrsUS$50.00k0.0089%
$ 139.5
Stephen Webster
Independent Director6.4yrsUS$65.00k0.014%
$ 221.0
Steven Gelone
Director2.7yrsUS$579.23k0.041%
$ 641.4
Charles Rowland
Independent Director6.4yrsUS$55.00k0.019%
$ 295.7
Theodore Schroeder
Director5.3yrsUS$753.56k0.26%
$ 4.1k
Lisa Dalton
Independent Director2.4yrsUS$47.50k0.011%
$ 176.5
Carrie Bourdow
Independent Director6.4yrsUS$52.50k0.012%
$ 192.0

6.4yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: NTY's board of directors are considered experienced (6.4 years average tenure).